Basel Medical Group Ltd
BMGL
$0.61
$0.024.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.42M | 2.33M | 1.89M | 1.91M | 1.83M |
| Total Other Revenue | 10.90K | 10.50K | 2.50K | 2.50K | -800.00 |
| Total Revenue | 2.43M | 2.34M | 1.89M | 1.91M | 1.83M |
| Cost of Revenue | 1.94M | 1.87M | 1.46M | 1.48M | 1.22M |
| Gross Profit | 484.90K | 467.50K | 429.10K | 433.80K | 615.70K |
| SG&A Expenses | 8.10K | 7.80K | 45.00K | 45.50K | 0.00 |
| Depreciation & Amortization | 319.10K | 307.70K | 131.80K | 133.30K | 97.40K |
| Other Operating Expenses | 761.90K | 734.60K | 466.10K | 471.20K | 400.00K |
| Total Operating Expenses | 3.03M | 2.92M | 2.10M | 2.13M | 1.71M |
| Operating Income | -604.20K | -582.50K | -213.80K | -216.20K | 118.30K |
| Income Before Tax | -4.13M | -3.98M | -118.80K | -120.10K | 172.30K |
| Income Tax Expenses | -160.70K | -154.90K | 100.00 | 100.00 | -103.30K |
| Earnings from Continuing Operations | -3.97M | -3.83M | -118.90K | -120.20K | 275.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 200.00 | 200.00 | -- | -- | -- |
| Net Income | -3.97M | -3.83M | -118.90K | -120.20K | 275.70K |
| EBIT | -604.20K | -582.50K | -213.80K | -216.20K | 118.30K |
| EBITDA | -570.70K | -550.20K | -206.20K | -208.40K | 123.50K |
| EPS Basic | -0.19 | -0.18 | -0.01 | -0.01 | 0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| EPS Diluted | -0.19 | -0.18 | -0.01 | -0.01 | 0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 21.32M | 21.32M | 16.25M | 16.25M | 16.25M |
| Average Diluted Shares Outstanding | 21.32M | 21.32M | 16.25M | 16.25M | 16.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |